Skip to content
Review Open access

Potential roles for transient receptor potential vanilloid 1 in heart failure with preserved ejection fraction

Oct 2026 · Channels · Vol 20 · 0 citations · 159 references
Medicine

TL;DR

The biological properties of TRPV1 are summarized, how its signaling might intersect with HFpEF pathophysiology is considered, experimental TRPV1-targeted interventions are reviewed, and the evidence needed before TRPV1 can be evaluated as a potential therapeutic target is identified.

Abstract

ABSTRACT Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome in which diastolic dysfunction develops against a background of interacting mechanisms: inflammation, oxidative stress, impaired calcium homeostasis, myocardial fibrosis, coronary microvascular dysfunction, mitochondrial impairment, and neurohumoral activation. Effective mechanism-targeted therapies remain limited. Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel expressed in cardiac sensory nerves, vascular endothelial cells, immune cells, and possibly other cardiovascular cell populations. It responds to diverse physical and chemical stimuli and may influence calcium handling, inflammatory signaling, oxidative stress, myocardial fibrosis, mitophagy, and ferroptosis. Preclinical studies have linked altered TRPV1 expression or activity to myocardial remodeling, impaired relaxation, microvascular dysfunction, and heart failure progression, but direct evidence in HFpEF is still sparse. This review summarizes the biological properties of TRPV1, considers how its signaling might intersect with HFpEF pathophysiology, reviews experimental TRPV1-targeted interventions, and identifies the evidence needed before TRPV1 can be evaluated as a potential therapeutic target.

Read PDF

Similar papers

Review Open access Sep 2026

Mitochondrial heterogeneity across cardiac cell types in heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous and increasingly prevalent syndrome for which effective disease-modifying therapies remain limited, in part because its multicellular pathophysiology remains incompletely understood. Mitochondrial dysfunction has emerged as an important contribut...

Anupriya Sinha, Devin W. Kolmetzky, Dhanendra Tomar et al. · 0 citations
Open access Sep 2026

Slow calcium removal contributes to impaired lusitropic response to β‐adrenergic stimulation in HFpEF mice

Abstract Heart failure with preserved ejection fraction (HFpEF) accounts for over half of heart failure cases, yet its underlying mechanisms remain incompletely understood and effective therapies are lacking. Diastolic dysfunction, a hallmark of HFpEF, may arise from impaired active myocardial relaxation, but the contr...

T. Zawadzki, Diana S. Usai, Sif G. Kaad et al. · 0 citations
Open access Oct 2026

Galectin-3 binding protein is upregulated in heart failure with preserved ejection fraction and is modulated by endothelial nitric oxide synthase deficiency

LGALS3BP is selectively elevated in HFpEF and mechanistically linked to eNOS-dependent endothelial dysfunction and mechanistically linked to eNOS-dependent endothelial dysfunction, identifying a novel pathway connecting metabolic stress, endothelial mal adaptation, and HFpEF pathophysiology.

R. Madonna, M. C. Cufaro, S. Gagliardi et al. · 0 citations
Open access Oct 2026

Hypertensive stress rewires macrophage signaling in heart failure with preserved ejection fraction independent of obesity

Heart failure with preserved ejection fraction (HFpEF) remains a major unmet clinical challenge. Although obesity is common in many HFpEF cohorts from Europe and North America, three Japanese HFpEF cohorts identified hypertension and sympathetic overactivation, rather than obesity, as dominant features. To model thes...

Yuya Kinoshita, Michio Sato, T. Kadomatsu et al. · 0 citations
Review Oct 2026

Calcium-Sensing Receptor-NLRP3 Inflammasome Signaling in Cardiovascular Diseases: Preclinical Evidence and Translational Perspectives.

The chronic low-grade inflammation driven by NLR family pyrin domain containing 3 (NLRP3) inflammasome is increasingly acknowledged as an underlying mechanism of myocardial infarction, heart failure, atrial fibrillation, hypertension, and atherosclerosis. Extracellular Ca2+, amino acids, and other ligands link to intra...

Satnam Singh Mehadwan, Gauri Chaturvedi, Nandini Dubey et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.